Miriam Berchuk, Anesthesiology Medicare: Medicare Enrolled Practice Location: 221 Mahalani St, Wailuku, HI 96793 Phone: 808-244-9056 |
Dr. Nicholas Scott Goehner, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 221 Mahalani St, Wailuku, HI 96793 Phone: 808-442-5064 Fax: 808-442-5067 |
Thomas Y Kim, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 221 Mahalani St, Wailuku, HI 96793 Phone: 808-244-9056 |
Kai Matthes, M.D., PH.D. Anesthesiology - Pediatric Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 221 Mahalani St, Wailuku, HI 96793 Phone: 808-442-5064 Fax: 808-442-5067 |
Mark Etter, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 221 Mahalani St, Wailuku, HI 96793 Phone: 808-244-9056 |
Dr. Thomas J Spallino, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 595 Kuikahi Dr, Wailuku, HI 96793 Phone: 808-244-9664 Fax: 808-244-8757 |
Marcus Aleksander Kuikka, MBBS Anesthesiology Medicare: May Accept Medicare Assignments Practice Location: 221 Mahalani St, Wailuku, HI 96793 Phone: 808-244-9056 |
Kimberly D Milhoan, M.D. Anesthesiology - Pediatric Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 221 Mahalani St, Wailuku, HI 96793 Phone: 808-442-5064 Fax: 808-442-5067 |
News Archive
The suit alleges that Guidant, a subsidiary of Boston Scientific Corp., knowingly sold defective defibrillators.
Even though the human papillomavirus (HPV) is a risk factor for certain head and neck cancers, its presence could make all the difference in terms of survival, especially for African Americans with throat cancer, say Henry Ford Hospital researchers.
Talyst, a market leader in pharmacy automation and 340B solutions, will be exhibiting at the 2014 American Society of Health-System Pharmacists MidYear Meeting in Anaheim, CA December 8 - 10. The company will be showcasing its acute care pharmacy automation solutions, long term care solutions and 340B software products and services.
Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostic tests, announced today the receipt of a new notice of allowance from the United States Patent and Trademark Office ("USPTO") for U.S. patent application 11/418,870, including claims related to Sanger hsa-miR-451. miR-451 is used in the Company's miRviewâ„¢ mets test, which accurately identifies the primary tumor site in patients with metastatic cancer and Cancer of Unknown Primary (CUP).
› Verified 9 days ago